Durvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLC
1 clinical trials · Condition
◉ Watch Durvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLC
| Record | Firm | Date |
|---|---|---|
| Pulmonary sarcomatoid_MEDI4736+Treme (NCT03022500) | Seoul National University Hospital | 2017-05-18 |
Track Durvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.